Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Gyros Protein Technologies
Gyros Protein Technologies
Activities:
Analysis
Pharmaceutical
X
LinkedIn
Trending Articles
Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success
Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
ChargePoint invest in a single-use manufacturing facility to expand product line
The single-use manufacturing facility will become fully operational in June 2024, and will support the company's trio of liquid and powder transfer devices
COVID-19 still a significant risk for the immunocompromised, study finds
AstraZeneca's INFORM study highlights the persistent danger of COVID-19 for the immunocompromised despite the vaccination scheme
Broughton receives flexible scope ISO 17025 accreditation
New certification allows accreditation without prior approval
Upcoming event
ASGCT Annual Meeting 2024
7-11 May, 2024 | Meeting | Portland, OR
See all
Related Content
Research & Development
Gyros Protein Technologies and Biotage partner to advance peptide purification efficiency
Partnership complements Gyros’ PurePep EasyClean technology offering with an automated solution for advanced discovery process
Manufacturing
Gyros Protein Technologies introduces updated peptide synthesiser
The device introduces real-time flow technology, a non-invasive method designed to continually monitor the flow rate of fluids within the system
Manufacturing
Gyros Protein Technologies introduces Gyrolab AAV9 Titer kit
The kit is designed to support AAV-based CGT production
Finance
Gyros Protein Technologies and Cygnus expand collaboration
The extension of the collaboration follows the launch of the ready-to-use Gyrolab CHO HCP and <i>E. coli</i> HCP kits, developed through a licensing and supply agreement with Cygnus
Manufacturing
Mesa Labs acquires Gyros Protein Technologies
The US-based quality control instrument supplier has acquired the Swedish protein synthesis solutions provider to begin its push into biopharmaceutical development
Manufacturing
Gyros Protein Technologies introduces lentivirus titre kit
Ready-to-use kit enabled lentivirus titre determinations during the manufacture of lentivirus vectors
Manufacturing
Gyros Protein Technologies debuts test for impurities in E. coli systems
New product is a host cell protein (HCP) kit for automated impurity analysis of biotherapeutics expressed in <i>E. coli</i> systems
Subscribe now